FTFinancial Times·2hBusiness
score-0.65
AstraZeneca Pivots Research Strategy After Wainua Trial Narrows Path to Reducing Cardiovascular Deaths
Original
AstraZeneca shares slide after heart treatment disappoints in trial
“Negative framing emphasizes clinical failure and financial loss. Words 'slide,' 'disappoints,' and 'did not meet' create concern without context on safety or future prospects.”